NEW YORK (GenomeWeb News) – Molecular diagnostics firm Transplant Genomics has raised $2.8 million toward a targeted $3 million in a private offering, the company said in a document filed with the US Securities and Exchange Commission on Friday.

The firm declined to identify the investors in the round, but a spokesperson said that the funds will be used to commercialize its first product, a test for improving the management of kidney transplant recipients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.